While our clinical trial has been through its third and final scheduled safety review by our independent data monitoring committee and we are nearing completion of enrollment, safety issues always take precedence. Boston Scientific has requested a short period to review these latest (serious adverse events), and we have accommodated their request.
-Richard Otto
Select a background
More quotes by Richard Otto
Popular Authors
A curated listing of popular authors.